Showing results 61 to 67 of 67
    1 2 3 4

Antithrombotic activity of BM-573, a novel thromboxane modulator, in rat arterial thrombosis model, pig myocardial infarction model and its effects on bleeding time
Hanson, Julien ; Kolh, Philippe ; Rolin, S. et al

Poster (2003, November)

Detailed reference viewed: 11 (1 ULg)

Pharmacological evaluation of the thromboxane A2 receptor antagonist BM-613
Hanson, Julien ; Rolin, S.; De Leval, X. et al

Poster (2003, May)

Detailed reference viewed: 2 (0 ULg)

Synthesis and pharmacological evaluation of BM-613, an original thromboxane A2 antagonist
Hanson, Julien ; Rolin, S.; De Leval, X. et al

Poster (2003, May)

Detailed reference viewed: 2 (0 ULg)

Etude de la sélectivité tissulaire d’un nouvel antagoniste des récepteurs au thromboxane A2, le BM-613
Hanson, Julien ; Rolin, S.; De Leval, X. et al

Poster (2003, January 31)

Detailed reference viewed: 4 (0 ULg)

Update on GPIIb/IIIa antagonists
Hanson, Julien ; De Leval, X.; Kolh, Philippe et al

in Expert Opinion on Therapeutic Patents (2003), 13

Detailed reference viewed: 5 (1 ULg)

BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane A2 receptors
Hanson, Julien ; Rolin, S.; De Leval, X. et al

in Blood (2003)

Detailed reference viewed: 28 (17 ULg)

Antithrombotic activity of BM-573, a novel thromboxane modulator, in rat arterial thrombosis model, pig myocardial infarction model and its effect on bleeding time
Dogné, Jean-Michel ; Kolh, Philippe ; Rolin, S. et al

in Blood (2003)

Detailed reference viewed: 22 (6 ULg)

    1 2 3 4